Evidence map›Paper›PMID 24369379›Full record

ArticleBrain : a journal of neurology2014

Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy.

Carla Giordano, Luisa Iommarini, Luca Giordano, Alessandra Maresca, Annalinda Pisano, Maria Lucia Valentino, Leonardo Caporali, Rocco Liguori, Stefania Deceglie, Marina Roberti and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 2 syntheses or guidelines pooled it, 283 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. A NovelInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Investigating PeripheralBiomolecules · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 10 institutions in 4 countries.

Carla Giordano1 Department of Radiology, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy.
Luisa Iommarini
Luca Giordano
Alessandra Maresca
Annalinda Pisano
Maria Lucia Valentino
Leonardo Caporali
Rocco Liguori
Stefania Deceglie
Marina Roberti
Francesca Fanelli
Flavio Fracasso
Fred N Ross-Cisneros
Pio D'Adamo
Gavin Hudson
Angela Pyle
Patrick Yu-Wai-Man
Patrick F Chinnery
Massimo Zeviani
Solange R Salomao
Adriana Berezovsky
Rubens Belfort
Dora Fix Ventura
Milton Moraes
Milton Moraes Filho
Piero Barboni
Federico Sadun
Annamaria De Negri
Alfredo A Sadun
Andrea Tancredi
Massimiliano Mancini
Giulia d'Amati
Paola Loguercio Polosa
Palmiro Cantatore
Valerio Carelli
University of Bari Aldo Moro · ITUniversity of Bologna · ITUniversidade Federal de São Paulo · BRNewcastle University · GBSapienza University of Rome · ITKeck Hospital of USC · USAzienda Ospedaliera San Camillo-Forlanini · ITMRC Mitochondrial Biology Unit · GBUniversidade de São Paulo · BRUniversity of Trieste · IT

Funding

VISION RESEARCHP30EY003040 · NEI · DOHENY EYE INSTITUTE · PI SUN, DEMING · 1985 to 2013
$7.0M
Medical Research Council G0701386Medical Research Council G1002570Medical Research Council MR/K000608/1NEI NIH HHS EY03040NEI NIH HHS P30 EY003040Telethon GGP06233Telethon GGP11182Telethon GPP10005Wellcome Trust 096919Wellcome Trust 101876
6 · The paper itself

Abstract

Leber's hereditary optic neuropathy is a maternally inherited blinding disease caused as a result of homoplasmic point mutations in complex I subunit genes of mitochondrial DNA. It is characterized by incomplete penetrance, as only some mutation carriers become affected. Thus, the mitochondrial DNA mutation is necessary but not sufficient to cause optic neuropathy. Environmental triggers and genetic modifying factors have been considered to explain its variable penetrance. We measured the mitochondrial DNA copy number and mitochondrial mass indicators in blood cells from affected and carrier individuals, screening three large pedigrees and 39 independently collected smaller families with Leber's hereditary optic neuropathy, as well as muscle biopsies and cells isolated by laser capturing from post-mortem specimens of retina and optic nerves, the latter being the disease targets. We show that unaffected mutation carriers have a significantly higher mitochondrial DNA copy number and mitochondrial mass compared with their affected relatives and control individuals. Comparative studies of fibroblasts from affected, carriers and controls, under different paradigms of metabolic demand, show that carriers display the highest capacity for activating mitochondrial biogenesis. Therefore we postulate that the increased mitochondrial biogenesis in carriers may overcome some of the pathogenic effect of mitochondrial DNA mutations. Screening of a few selected genetic variants in candidate genes involved in mitochondrial biogenesis failed to reveal any significant association. Our study provides a valuable mechanism to explain variability of penetrance in Leber's hereditary optic neuropathy and clues for high throughput genetic screening to identify the nuclear modifying gene(s), opening an avenue to develop predictive genetic tests on disease risk and therapeutic strategies.

Indexed as

PenetranceAdolescentAdultAgedAged, 80 and overDNA, MitochondrialFemaleHumansMaleMiddle AgedMitochondrial TurnoverOptic Atrophy, Hereditary, LeberPedigreeYoung AdultDNA, MitochondrialLHON penetrancemitochondrial biogenesismtDNA copy number

Identifiers

PMID24369379
PMCPMC3914475
OpenAlexW2138762261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.